Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study

• Päätekijät: Zihan Guo (Tekijä), Yunlan Ding (Tekijä), Mengmeng Wang (Tekijä), Qing Zhai (Tekijä), Jiyong Liu (Tekijä), Qiong Du (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2024-08-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

In this study, we compared the similarities and differences in adverse events (AEs) among CAR T-cell products through signal mining via the FDA Adverse Event Reporting System (FAERS) and identified unknown AEs to provide a reference for safe clinical medication. Data from the FAERS database spanning...